Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Iida

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Science Advances|March 29, 2023
Active recruitment of anti-PD-1-conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapyYixin Wang, Wen Li, Zhaoting Li, et al.
Cancer Biology & Therapy|June 14, 2013
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximabMari Iida, Toni M Brand, David A Campbell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2022
Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancerMahmoud Toulany, Mari Iida, Konstanze Lettau, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer modelsHanneke Stegeman, Johannes H Kaanders, Albert J van der Kogel, et al.
Carcinogenesis|December 25, 2004
Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogensMari Iida, Colleen H Anna, Wanda M Holliday, et al.
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Neoplasia (New York, N.Y.)|June 30, 2012
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibitionPaul A Clark, Mari Iida, Daniel M Treisman, et al.
Seminars in Radiation Oncology|June 18, 2023
Radiation Sensitivity: The Rise of Predictive Patient-Derived Cancer ModelsLiliana L Berube, Kwang-Ok P Nickel, Mari Iida, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Science Advances|March 29, 2023
Active recruitment of anti-PD-1-conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapyYixin Wang, Wen Li, Zhaoting Li, et al.
Cancer Biology & Therapy|June 14, 2013
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximabMari Iida, Toni M Brand, David A Campbell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2022
Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancerMahmoud Toulany, Mari Iida, Konstanze Lettau, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Cancers|January 23, 2024
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, RecruitKourtney L Kostecki, Mari Iida, Bridget E Crossman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer modelsHanneke Stegeman, Johannes H Kaanders, Albert J van der Kogel, et al.
Carcinogenesis|December 25, 2004
Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogensMari Iida, Colleen H Anna, Wanda M Holliday, et al.
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Neoplasia (New York, N.Y.)|June 30, 2012
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibitionPaul A Clark, Mari Iida, Daniel M Treisman, et al.
Seminars in Radiation Oncology|June 18, 2023
Radiation Sensitivity: The Rise of Predictive Patient-Derived Cancer ModelsLiliana L Berube, Kwang-Ok P Nickel, Mari Iida, et al.
Pageof 6